Pathology Microbiology And Immunology

Dr. Stahlman, professor of Pediatrics and Pathology, Microbiology and Immunology, is credited with establishing at Vanderbilt University Medical Center (VUMC) the nation’s first newborn intensive care unit to use monitored respiratory therapy in babies born with damaged lungs. Read More

Manuel Ascano, associate professor of biochemistry and pathology, microbiology and immunology, and Dr. Alissa Weaver, Cornelius Vanderbilt Chair and director of the Vanderbilt Center for Extracellular Vesicle Research, are one of nine U.S. research teams awarded funding from the National Science Foundation to more fully understand the potential biotechnological uses of RNA, ranging from crop disease protection to treatments that combat cancer. Read More

The “Molecular Muse” art exhibit on display in Light Hall is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology, and Inflammation Artist-in-Residence (VI4-AiR) program, which brings together scientists and artists to create and promote art as a visual science communication tool. Read More

Vanderbilt researchers have discovered that beneficial bacteria in the small intestines produce a compound that protects against obesity. Read More

Pasteurization of breast milk affects the concentration of osteopontin, a bioactive protein with roles in intestinal, immunological and brain development — suggesting that osteopontin supplementation should be considered when donor milk is provided to preterm infants. Read More

Vanderbilt researchers are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients. Read More

Vanderbilt's James E. Crowe, Jr, MD, and Neil Osheroff, PhD, are among 12 individuals honored by the Association of American Medical Colleges during its 2023 Awards Recognition Event. Read More

Vanderbilt research shows that commensal gut microbes impact the host-pathogen competition for iron and have implications for therapeutic strategies aimed at preventing pathogens from acquiring essential nutrients. Read More

Trans-institutional project connects Vanderbilt experts in drug delivery, stem cell engineering, biomanufacturing and cell biology to advance biomanufacturing of nanoparticles that can deliver precisely targeted drugs to the site of a disease. Read More

A Vanderbilt study found that a molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients. Read More

Vanderbilt researchers have demonstrated that a cluster of microRNAs — small pieces of RNA that regulate gene expression — work in a type of immune cells called macrophages to help protect against metabolic defects in obesity. Read More

Vanderbilt's Mariana Byndloss, DVM, PhD, is one of eight Burroughs Wellcome Fund 2023 Investigators in the Pathogenesis of Infectious Disease. Read More

Vanderbilt researchers detail the landscape of RNA editing — a form of RNA modification — in primary effusion lymphoma cells during Kaposi’s sarcoma-associated herpesvirus infection and identify an edited viral microRNA that is critical for infection. Read More

Vanderbilt's Wenhan Zhu, PhD, has received a three-year award from the G. Harold and Leila Y. Mathers Foundation to support his research that aims to answer a fundamental question about bacterial physiology and engineer probiotics to improve gut inflammatory diseases. Read More

An international consortium co-led by Vanderbilt's Rubén Martínez-Barricarte has discovered a new genetic disorder that causes immunodeficiency and profound susceptibility to opportunistic infections including a life-threatening fungal pneumonia.  Read More

New Vanderbilt research could inform therapeutic strategies for enhancing thymic function when desired — such as during aging, recovery from radiation therapy or chemotherapy, or other conditions that reduce T cell output. Read More

Gastrointestinal inflammation, such as occurs in inflammatory bowel disease, triggers the expansion of a population of “bone-eating” cells, leading to bone loss. Read More

Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs. Read More

A Vanderbilt study found that the bacterium Clostridioides difficile (C. difficile) may be a previously unrecognized contributor to colorectal cancer. Read More

Mariana Byndloss, assistant professor of pathology, microbiology and immunology, and William Wan, assistant professor of biochemistry, have been named 2022 Pew Scholars in the Biomedical Sciences. The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust have selected Alexander Bick, assistant professor of genetic medicine, to join the 2022 class of Pew-Stewart Scholars for Cancer Research.  Read More